First Pacific Advisors LP Purchases Shares of 45,480 Sotera Health (NASDAQ:SHC)

First Pacific Advisors LP purchased a new position in Sotera Health (NASDAQ:SHC) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 45,480 shares of the company’s stock, valued at approximately $540,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Victory Capital Management Inc. lifted its stake in shares of Sotera Health by 288.2% in the 4th quarter. Victory Capital Management Inc. now owns 72,092 shares of the company’s stock valued at $1,215,000 after purchasing an additional 53,520 shares during the last quarter. Charles Schwab Investment Management Inc. increased its stake in Sotera Health by 1.9% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 898,320 shares of the company’s stock worth $15,137,000 after purchasing an additional 16,401 shares during the period. Jump Financial LLC bought a new stake in shares of Sotera Health during the fourth quarter worth $501,000. Dimensional Fund Advisors LP grew its holdings in shares of Sotera Health by 22.3% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,992,717 shares of the company’s stock worth $33,581,000 after purchasing an additional 363,628 shares during the last quarter. Finally, Roubaix Capital LLC lifted its holdings in Sotera Health by 8.0% during the 4th quarter. Roubaix Capital LLC now owns 441,008 shares of the company’s stock valued at $7,431,000 after buying an additional 32,649 shares in the last quarter. Institutional investors own 91.03% of the company’s stock.

Sotera Health Trading Up 5.9 %

NASDAQ:SHC traded up $0.91 on Thursday, reaching $16.32. The company’s stock had a trading volume of 4,460,507 shares, compared to its average volume of 1,318,922. The firm has a market cap of $4.62 billion, a price-to-earnings ratio of 85.85 and a beta of 2.06. The company has a quick ratio of 2.59, a current ratio of 2.93 and a debt-to-equity ratio of 5.46. Sotera Health has a 12-month low of $10.71 and a 12-month high of $17.44. The stock has a 50 day moving average price of $13.75 and a 200 day moving average price of $12.79.

Sotera Health (NASDAQ:SHC) last released its earnings results on Monday, August 5th. The company reported $0.19 EPS for the quarter, topping the consensus estimate of $0.15 by $0.04. Sotera Health had a return on equity of 47.26% and a net margin of 3.65%. The firm had revenue of $277.00 million during the quarter, compared to analysts’ expectations of $266.45 million. During the same period in the previous year, the firm posted $0.19 EPS. Sotera Health’s revenue for the quarter was up 8.6% on a year-over-year basis. On average, equities analysts anticipate that Sotera Health will post 0.64 EPS for the current fiscal year.

Analysts Set New Price Targets

SHC has been the subject of several recent research reports. Barclays lifted their price objective on Sotera Health from $14.00 to $17.00 and gave the company an “overweight” rating in a report on Tuesday, August 6th. Piper Sandler began coverage on shares of Sotera Health in a research report on Tuesday, May 21st. They set a “neutral” rating and a $13.00 target price for the company. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and set a $17.00 price target on shares of Sotera Health in a research report on Tuesday, August 6th. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $15.70.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.